INSTITUTION Information Clause Samples

The INSTITUTION Information clause defines the requirements for providing and maintaining accurate details about the institution involved in the agreement. This typically includes specifying the institution’s legal name, address, and relevant contact information, and may require updates if any of these details change during the contract term. By clearly identifying the institution and ensuring up-to-date information, this clause helps prevent confusion or miscommunication and ensures that all parties can reliably contact and reference the correct entity throughout the agreement.
INSTITUTION Information. In the course of a Study, SPONSOR may be provided with or have access to information of Institution, Principal Investigator, and/or Study Personnel, including, without limitation, information relating to scientific data, business operations, procedures, technical information, medical records, financial information and personal information, which shall remain the property of Institution (collectively, “Institution Information”). All Institution Information shall be marked as confidential, provided that information which is not marked but that a reasonable person under the same or similar circumstances would understand to be confidential in nature shall also be considered Institution Information. SPONSOR will hold all Institution Information in confidence in accordance with the same terms that oblige Institution as set forth above in Sections 16.1, 16.2, and 16.3. SPONSOR will use the Institution Information solely for the purpose of the performance of this Agreement. Institution and Principal Investigator shall not disclose confidential Institution Information to Sponsor unless it is necessary to the Study.
INSTITUTION Information. This DoD Institutional Agreement for IRB Review describes the responsibilities of the engaged institution and the institution with the IRB. This Agreement, when signed, becomes part of the engaged institution’s Federal Assurance for the Protection of Human Research Subjects approved by DoD (and may become part of the Federalwide Assurance (FWA) approved by the Department of Health and Human Services (DHHS)). A. Engaged Institution Relying on the IRB B. Institution Supplying the IRB Services
INSTITUTION Information. Name: University of Arkansas, Fort ▇▇▇▇▇ Address: ▇▇▇▇ ▇▇▇▇▇ ▇▇▇; ▇.▇. Box 3649 Fort ▇▇▇▇▇, AR 72913 Contact Name: ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ Contact Email: ▇▇▇▇.▇▇▇▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇ Section IIFunding Information Grant funding is subject to the availability of funds appropriated by legislative act for the purpose stated in the grant award. ADE reserves to right to reduce or void the grant award upon appropriated funds becoming reduced or unavailable. In addition, a grant agreement may be terminated by ADE at any time for any reason upon notice to the grant recipient. ADE reserves the right to reduce funding if the initial funding projections are determined not to have been realistic based upon the number of actual applicants or other factors. Should additional funds become available for distribution, ADE will determine how these funds will be distributed. Program funds shall not be obligated for expenditure before the beginning date of the grant or after the ending date of the grant. Funds may be requested only for those items that are reasonable and necessary for accomplishing the objectives of the program as defined in the application notice and for implementing activities as described. Costs not included in the approved grant budget, including approved budget revisions, will not be reimbursed by ADE. Any costs that are incurred either before the start of the grant award or after the expiration of the grant award performance period are not allowable. INSTITUTION must receive the benefit and liquidate all obligations incurred under the grant award no later than June 30, 2017. For costs to be allowable to be charged to a grant, costs must generally meet the following criteria: • Be necessary and reasonable for the performance of the grant and be allocable under the applicable cost principles • Conform to limitations or exclusions set forth in the grant agreement as to types or amount of costs • Be consistent with policies and procedures that apply uniformly to federally or state-funded activities and activities funded from other sources • Be determined in accordance with generally accepted accounting principles (GAAP) • Be adequately documented. ADE will provide INSTITUTION up to $59,400.00 in grant funding for the ADE approved 2016 Computer Science Professional Development Program. Forward funding, not to exceed 50% of total program funding, in the amount of $29,700.00 will be made available to INSTITUTION on or before April 29, 2016. The remaining funding amount ...
INSTITUTION Information. Name: Arch Ford Education Service Cooperative Address: ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ Contact Name: ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ Contact Email: ▇▇▇▇▇▇.▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇▇ Section IIFunding Information Grant funding is subject to the availability of funds appropriated by legislative act for the purpose stated in the grant award. ADE reserves to right to reduce or void the grant award upon appropriated funds becoming reduced or unavailable. In addition, a grant agreement may be terminated by ADE at any time for any reason upon notice to the grant recipient. ADE reserves the right to reduce funding if the initial funding projections are determined not to have been realistic based upon the number of actual applicants or other factors. Should additional funds become available for distribution, ADE will determine how these funds will be distributed. Program funds shall not be obligated for expenditure before the beginning date of the grant or after the ending date of the grant. Funds may be requested only for those items that are reasonable and necessary for accomplishing the objectives of the program as defined in the application notice and for implementing activities as described. Costs not included in the approved grant budget, including approved budget revisions, will not be reimbursed by ADE. Any costs that are incurred either before the start of the grant award or after the expiration of the grant award performance period are not allowable. INSTITUTION must receive the benefit and liquidate all obligations incurred under the grant award no later than June 30, 2017. For costs to be allowable to be charged to a grant, costs must generally meet the following criteria: • Be necessary and reasonable for the performance of the grant and be allocable under the applicable cost principles • Conform to limitations or exclusions set forth in the grant agreement as to types or amount of costs • Be consistent with policies and procedures that apply uniformly to federally or state-funded activities and activities funded from other sources • Be determined in accordance with generally accepted accounting principles (GAAP) • Be adequately documented. ADE will provide INSTITUTION up to $104,172.60 in grant funding for the ADE approved 2016 Computer Science Professional Development Program. Forward funding, not to exceed 50% of total program funding, in the amount of $52,086.30 will be made available to INSTITUTION on or before April 29, 2016. The remaining funding amount will be made available ...
INSTITUTION Information. The name of the institution. The area code and telephone number of the institution.
INSTITUTION Information. Institute Name Institute Name Institution Type For-Profit Company/Institute Mailing Address Building # and Street Name City Postal Code Country Last Name (Surname) Last First Name (Given) First Middle (Second/Patronymic) Middle Position/Title Full Title PI E-mail Email 1 Alternative E-mail (optional) Email 2 Telephone # Country code + number Gender Choose an option… Highest Degree Degree Type Field/ Discipline Year Residency Status Choose an option....
INSTITUTION Information. In the course of a Trial, SPONSOR may be provided with or have access to information of Institution, Principal Investigator, and/or Trial Personnel, including, without limitation, information relating to scientific data, business operations, procedures, technical information, medical records, financial information and personal information, which shall remain the property of Institution (collectively, “Institution Information”). All Institution Information shall be marked as confidential, provided that information which is not marked but that a reasonable person under the same or similar circumstances would understand to be confidential in nature shall also be considered Institution Information. SPONSOR will hold all Institution Information in confidence in accordance with the same terms that oblige Institution as set forth above in Sections 16.1, 16.2, and 16.3.
INSTITUTION Information. Any information or materials provided to Pfizer by Institution related to the Study are non-confidential and will not contain any markings claiming confidentiality. Institution acknowledges that Pfizer will not treat such information or materials as confidential or assume any obligation to keep them confidential within the meaning of the following paragraph. Institution’s rights with respect to such information or materials will be only those obtained under patent laws and/or under a separate written agreement between Institution and Pfizer. Institution agrees that it has not, and will not, submit any confidential information to Pfizer in connection with the Study. Institution acknowledges that Pfizer may conduct ongoing or future research substantially similar or identical to the Study. “Institution Information” means: (i) the Protocol; (ii) the Study Report; (iii) a Publication until it is published; and (iv) information about a Product-Related Invention for which Pfizer has received a notice of invention. Pfizer will use Institution Information only for internal review and will disclose it only as required by Applicable Law. Pfizer’s obligations with respect to Product-Related Inventions in Section 5.5(iv) will survive until the earliest of: (a) filing of a patent application on the Product-Related Invention; (b) the Product-Related Invention owner(s) having notified Pfizer that they will not pursue a patent; or (c) one year after disclosure to Pfizer. Pfizer, které jsou nezbytné pro splnění právních požadavků, a 4.4.3. bude i nadále zachovávat důvěrnost těchto Důvěrných informací společnosti Pfizer ve vztahu ke všem ostatním třetím osobám.
INSTITUTION Information a. Provide the address of the financial institution’s corporate, regional and local headquarters. b. Acquisition/merger history: Indicate whether your institution has acquired, or has been acquired by another financial institution in the last three years. Specify the institution, the date of acquisition, and the information relative to geographical presence, operational changes, and amount of assets. c. Provide confirmation of your institution’s asset value and total deposits for calendar year ending 2021.

Related to INSTITUTION Information

  • Union Information On a quarterly basis, the Employer shall provide the Union with the name, address, telephone number, hire date, classification, employment status, and pay rate of bargaining unit members.

  • Transaction Information The Adviser shall furnish to the Trust such information concerning portfolio transactions as may be necessary to enable the Trust or its designated agent to perform such compliance testing on the Funds and the Adviser’s services as the Trust may, in its sole discretion, determine to be appropriate. The provision of such information by the Adviser to the Trust or its designated agent in no way relieves the Adviser of its own responsibilities under this Agreement.

  • Verizon Information Upon request by CBB, Verizon shall make available to CBB the following information to the extent that Verizon provides such information to its own business offices: a directory list of relevant NXX codes, directory and Customer Guide close dates, and Yellow Pages headings. Verizon shall also make available to CBB, on Verizon’s Wholesale website (or, at Verizon’s option, in writing) Verizon’s directory listings standards and specifications.

  • Maintaining Confidential Information Executive reaffirms his obligations under the Confidentiality Agreement. Executive acknowledges and agrees that the payments provided in Section 3 above shall be subject to Executive’s continued compliance with Executive’s obligations under the Confidentiality Agreement.

  • Confidential Information Protections 4.1 At all times during and after the Employee’s employment, the Employee will hold in confidence and will not disclose, use, lecture upon, or publish any of Company’s Confidential Information (defined below), except as may be required in connection with the Employee’s work for Company, or as expressly authorized by the Board. The Employee will obtain the written approval of the Board before publishing or submitting for publication any material (written, oral, or otherwise) that relates to the Employee’s work at Company and/or incorporates any Confidential Information. The Employee hereby assigns to Company any rights the Employee may have or acquire in any and all Confidential Information and recognize that all Confidential Information shall be the sole and exclusive property of Company and its assigns.